Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethics in Research01:56

Ethics in Research

26.3K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
26.3K
Nurses' Legal Responsibilities I01:27

Nurses' Legal Responsibilities I

2.4K
In healthcare, informed consent is a crucial process that involves thoroughly communicating medical treatment options to patients, including benefits, risks, potential side effects, and alternatives. This process enables patients to make well-informed decisions about their care, ensuring they understand the implications of their choices before consenting to or refusing treatment.
The legal responsibilities of a nurse regarding informed consent include the following:
2.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

518
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
518
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

393
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
393
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

895
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

373
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.

Thyroid : official journal of the American Thyroid Association·2010
Same author

Correlation between drugs of abuse and alcohol by hair analysis: parents at risk for having children with fetal alcohol spectrum disorder.

Alcohol (Fayetteville, N.Y.)·2010
Same author

Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction.

American journal of physiology. Heart and circulatory physiology·2010
Same author

Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity.

Canadian journal of physiology and pharmacology·2010
Same author

Severe extrapiramidal symptoms after nonintentional risperidone exposure in a child: case report and review of the literature.

American journal of therapeutics·2010
Same author

Pediatric cancer rates after universal folic acid flour fortification in Ontario.

Journal of clinical pharmacology·2010

Related Experiment Video

Updated: Apr 20, 2026

Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.4K

Informed consent in pediatric research.

Tom Leibson1, Gideon Koren

  • 1Division of Clinical Pharmacology and Toxicology at the Hospital for Sick Children, and University of Toronto, 555 University Ave., Toronto, ON, M5G 1X8, Canada, tom.leibson@sickkids.ca.

Paediatric Drugs
|November 26, 2014
PubMed
Summary

Informed consent for pediatric drug research faces challenges due to age, maturity, and regulatory gaps. Ensuring clear communication of risks and benefits is crucial for ethical clinical trials in children.

More Related Videos

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
08:42

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

Published on: July 31, 2017

8.9K
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.8K

Related Experiment Videos

Last Updated: Apr 20, 2026

Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.4K
A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
08:42

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research

Published on: July 31, 2017

8.9K
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.8K

Area of Science:

  • Pediatric Pharmacology
  • Bioethics
  • Clinical Trial Regulation

Background:

  • Pediatric drug research is increasingly standard for evaluating drug safety and efficacy in children.
  • Obtaining informed consent and assent from pediatric participants presents significant ethical and practical hurdles.

Purpose of the Study:

  • To review historical, ethical, and legal factors influencing informed consent in pediatric drug research.
  • To analyze the impact of age, maturity, and life circumstances on consent and assent processes.
  • To identify regulatory ambiguities in pediatric clinical trials.

Main Methods:

  • Literature review of historical, ethical, and legal aspects of informed consent in pediatric research.
  • Discussion of age-related considerations, maturity levels, and life circumstances.
  • Analysis of the interplay between parental consent and child assent.

Main Results:

  • Significant challenges exist in obtaining informed consent and assent for pediatric clinical trials.
  • Regulatory clarity is lacking, particularly concerning adolescents transitioning to autonomy.
  • Effective information transfer to guardians and children regarding risks and benefits is vital.

Conclusions:

  • Pediatric drug research requires careful navigation of informed consent and assent processes.
  • Addressing regulatory gaps and ensuring health literacy among guardians are essential for ethical research.
  • Balancing children's evolving autonomy with necessary protections remains a key challenge.